Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2005 Annual Meeting | Cerebrovascular Disease: Advances in Stroke

Friday 04/15/05
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
Gregory W. Albers, MD
Cerebrovascular Disease and Interventional Neurology
Upon completion:
Participants will become familiar with recent advances in medical, surgical, and interventional radiologic approaches to stroke treatment and prevention and learn the current guidelines for use of thrombolytic, anticoagulant, and antiplatelet agents in cerebrovascular patients.

The American Board of Psychiatry and Neurology has reviewed Cerebrovascular Disease: Advances in Stroke and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.
No CME available
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
09:00 AM - 09:40 AM What is and isn't CNS Vasculitis
Richard A. Bernstein, MD
09:40 AM - 10:20 AM Update on the Management of Intracerebral Hemorrhage
Christine A. Wijman, MD
10:20 AM - 10:35 AM Break
10:35 AM - 11:15 AM Management of Arteriovenous Malformations
J. P. Mohr, MD, FÂé¶¹´«Ã½Ó³»­
11:15 AM - 12:00 PM Intra-arterial Therapy for Acute Stroke
Jeffrey L. Saver, MD, FÂé¶¹´«Ã½Ó³»­
12:00 PM - 01:15 PM Lunch
01:15 PM - 01:55 PM Anticoagulant, Antiplatelet, and Thrombolytic Therapy: Current Guidelines
Gregory W. Albers, MD
01:55 PM - 02:35 PM TIAs: Definition, Diagnosis, and Management
J. D. Easton, MD, FÂé¶¹´«Ã½Ó³»­
02:35 PM - 02:50 PM Break
02:50 PM - 03:30 PM Modern Management of Carotid Stenosis
Pierre Fayad, MD, FAHA, FÂé¶¹´«Ã½Ó³»­
03:30 PM - 05:00 PM Interactive Case Presentations
Faculty Disclosures
Gregory W. Albers, MD No disclosure on file
Pierre Fayad, MD, FAHA, FÂé¶¹´«Ã½Ó³»­ Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Richard A. Bernstein, MD No disclosure on file
J. D. Easton, MD, FÂé¶¹´«Ã½Ó³»­ No disclosure on file
Christine A. Wijman, MD No disclosure on file
J. P. Mohr, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS .
Jeffrey L. Saver, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.